Register for email alerts and news feeds:
This journal | BMJ Group
rss
Tobacco Control 2004;13:78-84; doi:10.1136/tc.2003.005272
Copyright © 2004 by the BMJ Publishing Group Ltd.
Tobacco Control 2004;13:78-84
© 2004 BMJ Publishing Group Ltd

RESEARCH PAPER

Smoker and ex-smoker reactions to cigarettes claiming reduced risk

S Shiffman1, J L Pillitteri2, S L Burton3, M E Di Marino4

1 Pinney Associates and University of Pittsburgh, Pittsburgh, Pennsylvania, USA
2 Pinney Associates, Seattle, Washington, USA
3 GlaxoSmithKline Consumer Healthcare, Pittsburgh, Pennsylvania, USA
4 Pinney Associates, Bethesda, Maryland, USA

Correspondence to:
Correspondence to:
Saul Shiffman PhD
Pinney Associates, 201 North Craig Street, Suite 320, Pittsburgh, PA 15213, USA; shiffman{at}pinneyassociates.com

Context: The tobacco industry is introducing modified tobacco products claiming to reduce the risk of smoking (potential reduced exposure products, PREPs). If PREPs are perceived as safe, they may deter smokers from quitting and encourage re-initiation by smokers who have quit.

Objective: To assess smokers’ and ex-smokers’ perceptions of PREPs and the impact of PREP claims on interest in quitting (among smokers) or in resuming smoking (ex-smokers).

Design: A random-digit-dialled survey of US smokers and ex-smokers. We used Eclipse, a modified PREP cigarette, as an exemplar PREP. During the survey, the interviewer read risk reduction claims made for Eclipse by its manufacturer, assessing smokers’ interest in quitting before and after the exposure.

Participants: 1000 current cigarette smokers and 499 ex-smokers (300 quit within the last two years), over 18 years old.

Main outcome measures: Perception of risk reduction from Eclipse; interest in using Eclipse; smokers’ interest in quitting was assessed using a stage of change approach (pre- and post-exposure to claims).

Results: 91% of smokers thought Eclipse was safer than regular cigarettes. 24% believed Eclipse was completely safe. 57.4% of smokers were interested in using Eclipse; interest was greatest among smokers who were contemplating quitting. Exposure to Eclipse’s claims was followed by reduced interest in quitting. Among all ex-smokers, interest in Eclipse was 6.2%, but interest was 15.2% among young adults (18–25 years) who had stopped smoking within two years.

Conclusions: There is substantial risk that smokers will overinterpret reduced risk claims made for modified tobacco products. PREPs appeal to smokers who are contemplating quitting and exposure to reduced risk product claims appears to reduce smokers’ readiness to quit. PREPs also appealed to young adults who had recently stopped smoking. Thus, reduced risk tobacco product claims can undermine adult cessation and youth prevention, possibly resulting in increased harm even if the products are less toxic.

Keywords: modified tobacco products; reduced risk; smokers’ reactions


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Zeller, M., Hatsukami, D., and the Strategic Dialogue on Tobacco Harm Reducti, (2009). The Strategic Dialogue on Tobacco Harm Reduction: a vision and blueprint for action in the US. Tobacco Control 18: 324-332 [Abstract] [Full Text]  
  • Parascandola, M., Augustson, E., O'Connell, M. E., Marcus, S. (2009). Consumer awareness and attitudes related to new potential reduced-exposure tobacco product brands. Nicotine Tob Res 11: 886-895 [Abstract] [Full Text]  
  • Strasser, A A, Tang, K Z, Tuller, M D, Cappella, J N (2008). PREP advertisement features affect smokers' beliefs regarding potential harm. Tobacco Control 17: i32-i38 [Abstract] [Full Text]  
  • Biener, L., Bogen, K., Connolly, G. (2007). Impact of corrective health information on consumers' perceptions of "reduced exposure" tobacco products. Tobacco Control 16: 306-311 [Abstract] [Full Text]  
  • Pankow, J. F., Watanabe, K. H., Toccalino, P. L., Luo, W., Austin, D. F. (2007). Calculated Cancer Risks for Conventional and "Potentially Reduced Exposure Product" Cigarettes. Cancer Epidemiol. Biomarkers Prev. 16: 584-592 [Abstract] [Full Text]  
  • Wayne, G. F. (2006). Potential reduced exposure products (PREPs) in industry trial testimony. Tobacco Control 15: iv90-iv97 [Abstract] [Full Text]  
  • Tindle, H. A., Rigotti, N. A., Davis, R. B., Barbeau, E. M., Kawachi, I., Shiffman, S. (2006). Cessation Among Smokers of "Light" Cigarettes: Results From the 2000 National Health Interview Survey. AJPH 96: 1498-1504 [Abstract] [Full Text]  
  • Eissenberg, T (2006). The time for tobacco industry sponsored PREP evaluation has arrived. Tobacco Control 15: 1-2 [Full Text]  
  • Caraballo, R S, Pederson, L L, Gupta, N (2006). New tobacco products: do smokers like them?. Tobacco Control 15: 39-44 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.